Adverse Event reporting information can be found in footer

Request a Meeting

DOSING REGIMEN

NatSteroidAudit-SideImage-1

 

 

CORTIMENT LICENSED FOR THE TREATMENT OF ACTIVE
MICROSCOPIC COLITIS1

 

  • Indicated in adults for the induction of remission in patients with Active Microscopic Colitis1
  • CORTIMENT has a simple, once-daily 9 mg tablet dosing regimen, for up to 8 weeks1

90.5%

90.5%

CORTIMENT HAS A LOW PILL BURDEN ON PATIENTS1-3

CORTIMENT MMX – THE ONLY ORAL BUDESONIDE LICENSED FOR THE TREATMENT OF BOTH MILD TO MODERATE UC FLARES WHEN 5-ASA IS INSUFFICIENT, AND ACTIVE MICROSCOPIC COLITIS1-3,6

NatSteroidAudit-SideImage-1

 

 

 

  • European Microscopic Colitis guidelines recommend budesonide as 1st line treatment for Active Microscopic Colitis4
  • >90% of Microscopic Colitis patients have right- and left-sided disease7
  • 96% of CORTIMENT is delivered throughout the entire colon5
  • CORTIMENT has a simple dosing regimen:1
    • 1 x 9 mg tablet, once-daily, for up to 8 weeks
    • No requirement to dose taper
    • Taken with or without food

 

 

 

 

  • Cortiment 9 mg, Prolonged Release Tablets. SmPC.
  • Budenofalk 3 mg Gastro-resistant Capsules. SmPC.
  • Entocort CR 3 mg Capsules. SmPC.
  • Miehlke S, et al. United European Gastroenterol J. 2020;0(0):1–28.
  • Brunner M, et al. Br J Clin Pharmacol. 2006;61(1):31–38.
  • Budenofalk 9 mg Gastro-resistant Granules. SmPC.
  • Chapman T, et al. Gut. 2014;63:A130
  • Rawle MJ, et al. BMC Geriatr. 2018;18:118. doi:10.1186/s12877-018-0795-2.
  • Mims 2022
  • IMS Annual Retail Prescription Data 2020
About Microscopic Colitis
Managing Microscopic Colitis
Ulcerative Colitis
Prescribing Cortiment
Resources

Job Code: UK-COR-2200001 - Date of preparation: January 2022

cookiepopup

Our use of cookies

We use cookies (including third party cookies) to collect data while you use this website in order to make it work, keep it secure and comply with regulations. We’d also like your consent to use cookies so we can provide you with tailored content and advertising and analyse how you and other people use the website.

Select “On” to consent to our use of these cookies and continue to the website, or select “Off” to control which types of cookies we use. You can read more about cookies in our Privacy Policy.

Necessary cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytics cookies

We’d like to set Google Analytics cookies to help us to improve our website by collecting and reporting information on how you use it. The cookies collect information in away that does not directly identify anyone. For more information on how these cookies work, please see our Privacy Policy.